1999–2006 Cancer Incidence and Mortality DataThis Web-based report includes the official federal statistics on cancer incidence from registries that have high-quality data and cancer mortality statistics for each year and 2002–2006 combined. It is produced by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI), in collaboration with the North American Association of Central Cancer Registries (NAACCR).

Top 10 Cancer Sites: 2002-2006, Male, United States *†
Rates per 100,000 ‡
 All RacesWhiteBlackAsian Pacific Islander §American Indian/Alaska Native §Hispanic §||
1 Prostate
155.1		 Prostate
145.3		 Prostate
229.3		 Prostate
81.7		 Prostate
81.3		 Prostate
130.4
2 Lung and Bronchus
86.8		 Lung and Bronchus
86.2		 Lung and Bronchus
104.8		 Lung and Bronchus
50.2		 Lung and Bronchus
57.1		 Colon and Rectum
50.0
3 Colon and Rectum
59.1		 Colon and Rectum
58.2		 Colon and Rectum
67.9		 Colon and Rectum
43.8		 Colon and Rectum
37.4		 Lung and Bronchus
49.3
4 Urinary Bladder
37.9		 Urinary Bladder
40.0		 Kidney and Renal Pelvis
20.6		 Liver and Intrahepatic Bile Duct
21.0		 Kidney and Renal Pelvis
16.4		 Urinary Bladder
21.0
5 Non-Hodgkin Lymphoma
23.1		 Melanomas of the Skin
24.8		 Urinary Bladder
18.4		 Stomach
17.4		 Urinary Bladder
13.3		 Non-Hodgkin Lymphoma
19.8
6 Melanomas of the Skin
22.6		 Non-Hodgkin Lymphoma
23.7		 Non-Hodgkin Lymphoma
16.8		 Urinary Bladder
15.4		 Non-Hodgkin Lymphoma
11.5		 Kidney and Renal Pelvis
18.3
7 Kidney and Renal Pelvis
19.6		 Kidney and Renal Pelvis
19.7		 Oral Cavity and Pharynx
16.7		 Non-Hodgkin Lymphoma
14.6		 Oral Cavity and Pharynx
9.6		 Liver and Intrahepatic Bile Duct
16.1
8 Oral Cavity and Pharynx
15.9		 Leukemias
16.3		 Stomach
16.4		 Oral Cavity and Pharynx
10.5		 Stomach
9.2		 Stomach
14.3
9 Leukemias
15.9		 Oral Cavity and Pharynx
15.9		 Pancreas
16.3		 Pancreas
9.4		 Liver and Intrahepatic Bile Duct
8.7		 Leukemias
12.0
10 Pancreas
13.1		 Pancreas
12.9		 Myeloma
13.1		 Kidney and Renal Pelvis
9.0		 Leukemias
8.2		 Pancreas
11.4

   
(Table 4.1.M1) Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites with the Highest Rates within Race- and Ethnic-Specific Categories 

Footnotes

* Data are from selected statewide and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See registry-specific data quality information. Rates cover approximately 90% of the U.S. population.

† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.

‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130).

§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.

|| Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).

~ Rates are suppressed and not ranked if case counts are fewer than 16 or if the population of the specific category (race, ethnicity) is less than 50,000.

Confidence interval (CI): Range of values for a rate that will include the true value of the rate a given percentage of the time. Example: 95% CI includes the true value of the rate 95% of the time. 

Notes: ONS – Other Nervous System; NOS – Not Otherwise Specified; IBD – Intrahepatic Bile Duct. Urinary bladder cases include invasive and in situ